Chaohong Sun
AbbVie (United States)(US)
Publications by Year
Research Areas
Cell death mechanisms and regulation, Computational Drug Discovery Methods, Epigenetics and DNA Methylation, Protein Degradation and Inhibitors, Cancer-related gene regulation
Most-Cited Works
- → Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours(2017)825 cited
- → Structural Basis for the Inhibition of Caspase-3 by XIAP(2001)785 cited
- → Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain(2000)636 cited
- → Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer(2020)393 cited
- → Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer(2004)364 cited
- → NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP(1999)343 cited
- → NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP(2000)255 cited
- → The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex(2017)232 cited
- → Species differences and molecular determinant of TRPA1 cold sensitivity(2013)231 cited
- → Regulation of the Apaf-1/Caspase-9 Apoptosome by Caspase-3 and XIAP(2003)210 cited